Virology Market, By Product Type (DNA Viruses, RNA Viruses, Prions Diagnostic Test, and Other Viral Tests), By Viral Infection Controlling Method (Immunoprophylaxis, Active Prophylaxis, Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, and Immunomodulators), and Interferons), By Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, and Perinatal Infections), By End-User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI74319 | Publish Date: March 2024 | No. of Pages: 168

Global Virology Market By Product Overview

Introduction:

The virology market accounted for US$ 1.92 billion in 2020 and is estimated to be US$ 4.89 billion by 2030 and is anticipated to register a CAGR of 9.9%.

Virology is study of viruses including submicroscopic, parasitic particles of genetic material contained in a protein coat, and virus-like agents. Virology is concentrated on distribution, biochemistry, physiology, ecology, evolution, molecular biology, and clinical aspects of viruses. Viruses are responsible for controlled or developed diseases. Viruses have beneficial properties that can be used in gene therapy or vaccinology. According to data published by Institute of Human Virology (IHV), IHV has a unique HIV/AIDS vaccine which is designed to neutralize many different strains of HIV found across the globe. Virology starts when there was no procedure for propagating or visualizing viruses or specific laboratory tests for viral infection. The methods for separating viral nucleic acids (RNA & DNA) and proteins, which are now the mainstay of virology, did not exist. Thousand of different viruses are now known about virologists often specialize in either the viruses that infect plants, or bacteria and other microorganisms, or animals. Virologists are scientists who examine, study, and explore viruses and viral diseases. Moreover, they are responsible for studying the growth, development, characteristics, and structure of various viruses.

Global Virology Market By Product Dynamics

Prevalence of viral diseases across the globe is driving the virology market. In addition, increasing public awareness programs across the globe on Flu, Zika virus, STDs, AIDS, and Ebola virus is also expected to propel the target market. Furthermore, rising demand for R&D application from healthcare sector for cure and prevention of diseases is expected to fuel the virology market. Moreover, various treatments and diagnostic processes utilize virology applications is augmenting the target market. Recent, outbreak of corona virus had a adverse effect on health worldwide is the another factor which boost the growth of the target market.

However, maintaining the quality and safety standards of viral a controlling therapy may restrain the virology market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Virology Market By Product Segmentation

The virology market is segmented based on product type, viral infection controlling method, application, end-user, and region.

On the basis of product type, the target market is segmented into DNA viruses, RNA viruses, prions diagnostic test, and other viral tests. On the basis of viral infection controlling method, the virology market is categorized into the immunoprophylaxis, active prophylaxis, passive prophylaxis, antiviral chemotherapy, and interferons. On the basis of application, the target market is divided into skin and soft tissue infections, respiratory tract infections, GI tract infections, urinary tract infection, eye infections, sexually transmitted diseases, and perinatal infections. On the basis of end-user, the virology market is classified into hospitals, clinics, laboratories, diagnostic centers, blood banks, and pharmacies.

Regional Insights:

The virology market accounted for US$ 1.92 billion in 2020 and is estimated to be US$ 4.89 billion by 2030 and is anticipated to register a CAGR of 9.9%. On region the virology market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America virology market is expected to account for largest share in terms of revenue in the virology market over the forecast period. This is attributed to technological advancements such as the increasing rapid and portable diagnostics in countries such as U.S. of the region. Asia Pacific virology market is expected to account for second-highest share in terms of revenue in the virology market in the near future. This is owing to growing healthcare infrastructure, facilitated to diagnostics, and affordability of diagnostic tests for viral diseases in countries of the region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2019

Forecast period

2020 – 2030

Market representation

Revenue in USD Billion & CAGR from 2020 – 2030

Market Segmentation

By Product Type- DNA viruses, RNA viruses, Prions diagnostic test, and Other viral tests

By Viral Infection Controlling Method– Immunoprophylaxis, Active prophylaxis, Passive Prophylaxis, Antiviral Chemotherapy, (Veridical Agents, Antiviral Agents, and Immunomodulators) and Interferons

By Application– Skin and soft tissue infections, Respiratory tract infections, GI tract infections, Urinary tract infection, Eye infections, Sexually transmitted diseases, and Perinatal infections

By End-User- Hospitals, Clinics, Laboratories, Diagnostic centers, Blood banks, and Pharmacies

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the virology market report based on product type, viral infection controlling method, application, end-user, and region.

 

 

SEGMENTATION - Virology Market

Virology Market, By Region:

  • North America
    • Middle East & Africa
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • U.S.
    • Canada

Global Virology Market By Product Key Players

The key players operating in the virology market includes GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck KGaA, Novartis International AG, Siemens AG, Johnson & Johnson, AstraZeneca AB, Roche Holding AG, and Abivax SA. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the virology market.

Global Virology Market By Product Company Profile

  • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boehringer Ingelheim Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Fritz Hoffmann-La Roche
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abivax SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Virology Market By Product Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Preview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Viral Infection Controlling Method
      • Market Snippet, By Application
      • Market Snippet, By End-User
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Impact Analysis
    • PEST Analysis
    • Porter’s Analysis
  4. Market Segmentation, By Product Type, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • DNA Viruses
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • RNA Viruses
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Prions Diagnostic Test
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Other Viral Tests
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  5. Market Segmentation, By Viral Infection Controlling Method, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Immunoprophylaxis
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Active Prophylaxis
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Passive Prophylaxis
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Antiviral Chemotherapy
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
        • Veridical Agents
        • Antiviral Agents
        • Immunomodulators
    • Interferons
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  6. Market Segmentation, By Application, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Skin and Soft Tissue Infections
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Respiratory Tract Infections
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • GI Tract Infections
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Urinary Tract Infection
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Eye Infections
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Sexually Transmitted Diseases
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Perinatal Infections
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  7. Market Segmentation, By End-User, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Clinics
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Laboratories
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Diagnostic Centers
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Blood Banks
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Pharmacies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  8. Global Market, By Region, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Viral Infection Controlling Method, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Viral Infection Controlling Method, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Viral Infection Controlling Method, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Viral Infection Controlling Method, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Product Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Viral Infection Controlling Method, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By End-User, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • GlaxoSmithKline plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Boehringer Ingelheim Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • AbbVie Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • AstraZeneca PLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Fritz Hoffmann-La Roche
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Abivax SA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
    • Analyst Views
  10. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The global virology market is segmented based on product type, viral infection controlling method, application, end-user, and region.

Public awareness programmers conducted worldwide on Flu, Zika virus, STDs, AIDS, and Ebola virus are also a key factor increasing public awareness and eventually influencing the market growth. The virology market is constantly catering to the prevention and cure needs put forth by the healthcare sector.

North America virology market is expected to account for largest share in terms of revenue in the global virology market over the forecast period.

The key players operating in the global virology market includes GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck KGaA, Novartis International AG, Siemens AG, Johnson & Johnson, AstraZeneca AB, Roche Holding AG, and Abivax SA. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global virology market.